Bio & Pharma
-
Bio & Pharma
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean la...
May 07, 2024 (Gmt+09:00)
4 Min read -
Bio & Pharma
Samsung Life Science invests in US biotech firm Latus Bio
Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the l...
May 03, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Lunit, Radiobotics team up to enter EMEA markets
South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS ...
May 02, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and anticanc...
May 02, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
JLK to supply medical AI solutions in Indonesia
South Korea’s JLK Inc., an AI-based stroke care platform maker, announced on Tuesday that it signed a business agreement with medical consultin...
Apr 30, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
NGeneBio to transfer NGS tech to UAE company
South Korean medical diagnostic company NGeneBio Co. announced on Tuesday that it signed a contract with the United Arab Emirates (UAE)-based medical...
Apr 30, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Korean botox sales gain momentum in US, China
South Korea is ramping up exports of botulinum toxin to the US and China, the world’s two top consumers of the neurotoxin protein, with its pri...
Apr 29, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
HK inno.N to release K-CAB in MENA market
South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharma...
Apr 23, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara. Th...
Apr 23, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC i...
Apr 19, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales
Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own mar...
Apr 16, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Bio startup ArtBlood attracts $4.8 mn investment
South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment ...
Apr 09, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
KKR, Hanmi heirs likely to join hands for controlling stake
The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its s...
Apr 02, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Genesystem enters Indian tuberculosis treatment market
Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kits...
Mar 27, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Global quest to find modern elixirs enters new chapter
NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic el...
Mar 26, 2024 (Gmt+09:00)
4 Min read -
Bio & Pharma
Medytox to supply $73 mn botulinum toxin to Brazilian firm
South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceut...
Mar 26, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development business...
Mar 24, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
SK Bioscience exports Sky Cellflu to Thailand
South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured i...
Mar 21, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Drug maker Boryung targets its highest-ever sales in 2024
Boryung Corp., formerly Boryung Pharmaceutical Co., aims to join the 1 trillion won ($748 million) sales club this year, driven by new chronic diseas...
Mar 20, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Samsung invests in BrickBio in US
Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technolog...
Mar 19, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Reversing age possible in a decade: Harvard Prof. David Sinclair
Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, about...
Mar 18, 2024 (Gmt+09:00)
long read -
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US ma...
Mar 18, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Vivid Health gets seed round from Kakao Ventures
Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investmen...
Mar 06, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion ships initial supply of Zymfentra to US
South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tre...
Feb 29, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
GC Biopharma aims to boost Alyglo sales sixfold in the US
CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its im...
Feb 28, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Samsung targets gene therapy sector through US investments
Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is se...
Feb 27, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
SK C&C wins Korea’s nod for brain infarct diagnosis AI solution
SK Inc C&C (SK C&C), the information technology service unit of South Korea’s SK Group, said on Thursday it has secured medical device ...
Feb 22, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis to supply Hadlima to US government
South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and development...
Feb 21, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combines...
Feb 19, 2024 (Gmt+09:00)
1 Min read
Hidden Champions
-
T-Robotics
Published: Mar 25, 2021
Last updated: Jan 30, 2023
-
Point Mobile
Published: Sep 14, 2021
Last updated: May 10, 2022
-
Koh Young Technology Inc
Published: Sep 21, 2020
Last updated: Jan 20, 2023
-
Jong Ie Nara
Published: May 26, 2021
Last updated: Apr 15, 2022
-
DCM
Published: Dec 09, 2022
Last updated: Jan 30, 2023
Future Unicorns
Latest News